A comparison of 692 early invasive breast cancer with, and 1564 without, a family history of breast cancer showed that the former were younger at diagnosis (P ¼ 0.002), had smaller tumours (P ¼ 0.012), were more frequently oestrogen receptor positive (P ¼ 0.006) and diagnosed preclinically (Po0.001). A long recognised risk factor for breast cancer is a family history of the disease, although the majority of affected women do not have an affected close relative, and only 5 -10% do have a true hereditary predisposition (Carter, 2001). The overall risk of developing breast cancer is 1.9-3.9 times higher in women with an affected mother or sister (Collaborative Group on Hormonal Factors in Breast Cancer, 2001), but only a few studies have investigated the characteristics of breast cancer in women with a family history. We analysed the pathological, biological and clinical features of breast cancer in patients with (FH þ ) and without (FHÀ) a family history of breast cancer, the former being further subdivided into those with an affected first-or second-degree relative.
MATERIALS AND METHODSA total of 2256 women with early invasive operable breast cancer, who underwent surgery at Verona Hospitals between January 1992 and April 2001, were asked at their first visit whether they had any first-or second-degree relatives who had had breast cancer. Our analysis first compared those reporting at least one affected relative (FH þ ) with those reporting no affected relative (FHÀ); subsequently, the FH þ patients were divided into those with at least one first-degree relative (1st DFH) and those with only second-degree relatives with breast cancer (2nd DFH): only firstand second-degree relatives were considered in order to reduce ascertainment bias. Answers were always checked at the subsequent visit (at the time of the first cycle for the patients receiving chemotherapy, after 3 months for the others).All of the patients were assigned a UICC pathological TNM stage. On the basis of pathologist-defined tumour size, patients were divided into three categories: pT1 (o2 cm), pT2 (2 -5 cm) and pT3 (45 cm); the number of pathologically positive axillary nodes was divided into none, o3, 4 -10 and 410; tumour grading was recorded as G1 (well differentiated), G2 (moderately differentiated) or G3 (undifferentiated).Immunohistochemistry (IHC) defined oestrogen (ER) and progesterone receptor (PgR) status and was considered positive if more than 10% of the cells were stained for either. The replicative cell fraction was IHC stained using the Ki-67 monoclonal antibody (Mab-DAKO-PC); given the lack of an accepted cutoff point, the results were arbitrarily classified as low, medium or high (p10%, 11 -25% or 425% of stained cells). CerbB-2 levels were determined by IHC using the DAKO-PC monoclonal antibody, and considered positive if at least one cell was stained.At their first visit to the Department of Medical Oncology, all patients were asked about their disease presentation and divided into those who underwent mammography and ultrasonogra...